Arizona State Retirement System Morphic Holding, Inc. Transaction History

Arizona State Retirement System

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$26.12 - $34.07 $5,276 - $6,882	202 Added 2.46%	8,404 $286,000
Q1 2024 May 07, 2024	BUY	$26.64 - $40.31 $4,342 - $6,570	163 Added 2.03%	8,202 $288,000
Q4 2023 Jan 24, 2024	BUY	$19.95 - $31.0 $160,378 - $249,209	8,039 New	8,039 $232,000
Q2 2023 Aug 01, 2023	BUY	$34.33 - $62.11 $49,606 - $89,748	1,445 Added 23.52%	7,588 $435,000
Q1 2023 Apr 27, 2023	BUY	$26.01 - $48.69 $159,779 - $299,102	6,143 New	6,143 $231,000
Q2 2022 Jul 28, 2022	SELL	$19.74 - $43.01 $98,621 - $214,877	-4,996 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$36.25 - $52.02 $3,298 - $4,733	91 Added 1.86%	4,996 $201,000
Q4 2021 Feb 04, 2022	SELL	$43.27 - $65.72 $1,168 - $1,774	-27 Reduced 0.55%	4,905 $232,000
Q3 2021 Nov 12, 2021	BUY	$53.61 - $67.5 $2,466 - $3,105	46 Added 0.94%	4,932 $279,000
Q2 2021 Aug 02, 2021	SELL	$45.13 - $64.99 $37,818 - $54,461	-838 Reduced 14.64%	4,886 $280,000
Q1 2021 May 06, 2021	BUY	$29.77 - $84.85 $170,403 - $485,681	5,724 New	5,724 $362,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.